NEW DELHI – The Ministry of Health and Family Welfare today said its laws and regulatory framework ensure “high standards of quality, safety and efficacy” of domestically produced medicines.
The ministry’s comments come in the wake of a series of press reports misquoting the Drug Controller General of India G.N. Singh, as claimed by the government.
“A section of the print media–Indian as well as foreign–has recently published factually incorrect and largely unsubstantiated news item about the Indian national regulatory authority and Indian drug industry,” the ministry said in a press note.
“It is further reiterated that the Indian laws and India’s robust regulatory framework ensures the high standards of quality, safety and efficacy of drugs manufactured in the country,” the note said.
It added that the allegations made in the news items appeared to be baseless and were solely printed with the intension of harming the reputation of the Indian national regulatory authority as well as Indian drug industry.
